Help is on the way for women with low sex drives. The drug maker Proctor and Gamble has created a new patch will help women to regain their sex drive. The patch, named Intrinsa, is made of clear material to be worn on the abdomen where it delivers a low dose of testosterone. Intrinsa will be available by prescription, starting in April. It is intended, "for women who have had an early menopause because of surgery."
Key Themes Behind This Trend
- Female Sexual Health
- Intrinsa is a clear indication of the trend in the medical industry towards developing products that help women with low sex drives, creating potential innovation opportunities for drug-makers to further develop female sexual health treatments.
- Transdermal Patches
- The Intrinsa patch shows a rise in the popularity of transdermal patches, indicating potential opportunities for companies to develop more medical treatments delivered through the skin.
- Testosterone Replacement Therapy
- Intrinsa's use of low-dose testosterone through a patch shows a rise in the trend of testosterone replacement therapy, indicating potential opportunities for drug companies to further the effectiveness of the treatment seen in Intrinsa.
Where This Applies
- Pharmaceuticals
- The pharmaceutical industry is at the forefront of the trend in developing products that address female sexual health issues, indicating strong innovation opportunities for drug companies.
- Medical Devices
- Intrinsa's delivery through a wearable patch highlights the trend for wearable medical devices, highlighting potential opportunities for companies to design similar devices.
- Biotech and Life Sciences
- Intrinsa's clear material and use of testosterone replacement therapy indicate a trend in the biotech and life sciences field towards developing new and innovative solutions to women's health issues, creating potential market opportunities for companies in this space.
